MCHI vs KURE
YTDYear to date
KURE wins+23.3 pts
Past year
KURE wins+19.3 pts
Fee
MCHI winslower fee
Yield
KURE wins+1.7 pts
AUM
MCHI51.4× more
3–1KURE wins
MCHI and KURE · year-to-date · as of Nov 6, 2026 · AUM not scored
KURE vs S&P 500
YTD$18.79 · +0.3% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareS&P 500+ Peer avg+ Add a fund
Return1D1M3MYTD ▼1Y3Y5YMAX
Total return+0.3%+0.8%−0.1%+10.3%+2.8%+9.1%−35.9%−7.3%
Peer average+0.1%−2.2%−12.6%−11.5%−13.6%+25.6%−23.6%—
S&P 500 · VOO+0.3%−5.0%−4.6%+8.7%+9.8%+80.8%+71.8%+793.2%
KraneShares KURE and Vanguard VOO · total return, dividends in · as of Nov 6, 2026
KURE’s Holdings
Today6160.HKBeone Medicines9.3%1801.HK8.1%2269.HK7.4%603259.SS5.6%600276.SS4.6%300760.SZ4.4%9926.HK4.0%1177.HK3.9%1093.HK3.4%2359.HK3.3%3692.HK3.1%1548.HK2.7%688271.SS2.4%000538.SZ2.4%1530.HK2.1%6990.HK2.1%300015.SZ2.1%600436.SS2.0%002422.SZ1.9%300759.SZ1.8%1099.HK1.6%31 more
6160.HKBeone Medicines9.3%1801.HK8.1%2269.HK7.4%603259.SS5.6%600276.SS4.6%300760.SZ4.4%9926.HK4.0%1177.HK3.9%1093.HK3.4%2359.HK3.3%3692.HK3.1%41 more
BiotechnologyDrug Manufacturers - SpecialtyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - DevicesMedical - PharmaceuticalsOther
KraneShares KURE · 53 holdings · tile size = share of the fund · as of Nov 6, 2026
All 25 China ETFs
YTD| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | MCHI | MSCI ChinaReadDesk | 0.59% | 2.1% | −13.1% | −13.1% | $5.8B | |
| 2 | KWEB | KraneShares CSI China InternetReadDesk | 0.69% | 8.4% | −26.9% | −26.9% | $4.4B | |
| 3 | FXI | China Large-CapReadDesk | 0.73% | 1.9% | −8.1% | −8.1% | $4.0B | |
| 4 | CQQQ | China TechnologyReadDesk | 0.65% | 2.8% | −22.7% | −22.7% | $1.8B | |
| 5 | ASHR | Xtrackers Harvest CSI 300 China A-ReadDesk | 0.65% | 2.5% | −7.2% | −7.2% | $1.3B | |
| 6 | GXC | State Street SPDR S&P ChinaReadDesk | 0.59% | 2.3% | −11.7% | −11.7% | $436M | |
| 7 | CXSE | WisdomTree China ex-State-Owned EnterprisesReadDesk | 0.32% | 2.1% | −17.4% | −17.4% | $365M | |
| 8 | FLCH | Franklin FTSE ChinaReadDesk | 0.19% | 2.5% | −13.1% | −13.1% | $270M | |
| 9 | CNYA | MSCI China AReadDesk | 0.60% | 2.1% | −10.3% | −10.3% | $161M | |
| 10 | KURE | KraneShares MSCI All China Health CareReadDesk | 0.79% | 3.8% | +10.3% | +10.3% | $113M | |
| 11 | KBA | KraneShares Bosera MSCI China A 50 ConnectReadDesk | 0.79% | 1.7% | −8.2% | −8.2% | $107M | |
| 12 | CHIQ | Global X - MSCI China Consumer DiscretionaryReadDesk | 0.65% | 1.7% | −20.3% | −20.3% | $101M | |
| 13 | PGJ | Golden Dragon ChinaReadDesk | 0.70% | 1.9% | −21.0% | −21.0% | $80.2M | |
| 14 | ECNS | MSCI China Small-CapReadDesk | 0.59% | 7.1% | −17.0% | −17.0% | $58.4M | |
| 15 | CNQQ | Rayliant-ChinaAMC Transformative China TechReadDesk | 0.75% | 0.5% | −17.6% | −17.6% | $43.8M | |
| 16 | KGRN | KraneShares MSCI China Clean TechnologyReadDesk | 0.79% | 1.0% | −17.8% | −17.8% | $43.6M |
1–16 of 25Page 1 of 2
China · current AUM · as of Nov 6, 2026
KURE Payouts by Year
8YLatest payout, Dec 2025
$0.71
a share · once a year
3.8% yield
3.8% yield
8 years added up
$5.21 a share
$5.21 a share
KraneShares KURE · per-share distributions by ex-date · 2018–2025
KURE’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | MCHI | iShares MSCI China ETFReadVersus | 0.59% | 2.1% | −0.3% | −13.1% | −16.5% | $5.8B | |
| 2 | KWEB | KraneShares CSI China Internet ETFReadVersus | 0.69% | 8.4% | +0.5% | −26.9% | −32.9% | $4.4B | |
| 3 | FXI | iShares China Large-Cap ETFReadVersus | 0.73% | 1.9% | 0.0% | −8.1% | −10.5% | $4.0B | |
| 4 | CQQQ | Invesco China Technology ETFReadVersus | 0.65% | 2.8% | −0.2% | −22.7% | −25.8% | $1.8B | |
| 5 | ASHR | Xtrackers Harvest CSI 300 China A-Shares ETFReadVersus | 0.65% | 2.5% | −0.2% | −7.2% | −5.3% | $1.3B | |
| 6 | KURE | KraneShares MSCI All China Health Care Index ETFThis fund | 0.79% | 3.8% | +0.3% | +10.3% | +2.8% | $113M |
#1 of 25 this year · #17 cheapest of 25 · sorted by assetsOpen the Thematic table →
KURE and its peer group · total return · as of Nov 7, 2026
Cards for This View
KURE’s Top 10 Holdings
Today54.0%of KURE sits in these 10
16160.HBeone Medicines9.32%
21801.HInnovent Biologics8.13%
32269.HWuxi Biologics Cayman7.37%
4603259Wuxi Apptec -A5.64%
5600276Jiangsu Hengrui Pharmaceut-A4.57%
6300760Shenzhen Mindray Bio-Medic-A4.39%
79926.HAkeso4.03%
81177.HSino Biopharmaceutical3.89%
91093.HCspc Pharmaceutical Group Lt3.42%
102359.HWuxi Apptec -H3.25%
KraneShares KURE · weight in the fund · as of Nov 6, 2026
KURE’s Holdings
Today6160.HKBeone Medicines9.3%1801.HK8.1%2269.HK7.4%603259.SS5.6%600276.SS4.6%300760.SZ4.4%9926.HK4.0%1177.HK3.9%1093.HK3.4%2359.HK3.3%3692.HK3.1%1548.HK2.7%688271.SS2.4%000538.SZ2.4%1530.HK2.1%6990.HK2.1%300015.SZ2.1%600436.SS2.0%002422.SZ1.9%300759.SZ1.8%1099.HK1.6%31 more
6160.HKBeone Medicines9.3%1801.HK8.1%2269.HK7.4%603259.SS5.6%600276.SS4.6%300760.SZ4.4%9926.HK4.0%1177.HK3.9%1093.HK3.4%2359.HK3.3%3692.HK3.1%41 more
BiotechnologyDrug Manufacturers - SpecialtyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - DevicesMedical - PharmaceuticalsOther
KraneShares KURE · 53 holdings · tile size = share of the fund · as of Nov 6, 2026
KURE vs Peer Average
YTDKUREAvsBPeer average
1D+0.3%+0.1%
1M+0.8%−2.2%
3M−0.1%−12.6%
YTD+10.3%−11.5%
1Y+2.8%−13.6%
3Y+9.1%+25.6%
5Y−35.9%−23.6%
5–2KURE wins
24 China peers · each row scaled to its leader